Table 1.
Clinical data from the young groups
| Variable | STEMI | Control | P |
|---|---|---|---|
| (n = 86) | (n = 79) | ||
| Age, y | 40.00 (23, 44) | 39.94 (27, 44) | 0.317 |
| Male, n (%) | 76 (88.37) | 42 (53.16) | <0.001 |
| BMI (kg/m2) | 27.96 ± 2.80 | 25.16 ± 3.15 | 0.127 |
| Systolic pressure (mmHg) | 133.59 (90, 200) | 134.82 (100, 190) | 0.629 |
| Diastolic pressure (mmHg) | 81.03 (50, 124) | 83.37 (60, 140) | 0.957 |
| Pulse pressure (mmHg) | 52.67 (25, 90) | 51.71 (30, 90) | 0.608 |
| Fasting blood sugar (mmol/L) | 6.39 (3.76, 18.00) | 5.25 (3.25, 12.35) | <0.001 |
| HbA1C (%) | 6.26 ± 1.69 | 5.45 ± 1.12 | 0.018 |
| CK (U/L) | 1950.28 ± 1639.52 | 81.15 ± 44.60 | <0.001 |
| CKMB (U/L) | 163.99 ± 127.38 | 14.77 ± 13.35 | <0.001 |
| TNI (ng/mL) | 3.08 (0.11, 30) | 0.07 (0.05, 0.3) | <0.001 |
| TG (mmol/L) | 2.37 ± 2.48 | 2.25 ± 1.26 | 0.201 |
| TC (mmol/L) | 5.14 ± 1.39 | 4.65 ± 0.87 | 0.002 |
| NHDL-C (mmol/L) | 4.06 ± 1.35 | 3.53 ± 0.87 | 0.002 |
| HDL-C (mmol/L) | 1.07 ± 0.27 | 1.12 ± 0.26 | 0.856 |
| Fib (g/L) | 3.39 (1.90, 7.52) | 2.87 (1.78, 5.30) | <0.001 |
| Hypertension, n (%) | 41 (47.67) | 35 (44.30) | 0.755 |
| Type II diabetes, n (%) | 18 (20.93) | 17 (21.52) | 1.000 |
| Cerebrovascular diseases, n (%) | 6 (6.98) | 2 (2.53) | 0.281 |
| Alcohol drinking, n (%) | 25 (29.07) | 19 (24.05) | 0.486 |
| Smoking, n (%) | 71 (82.56) | 39 (49.37) | <0.001 |
| Smoking index | 329.53 (0, 1200) | 179.49 (0, 900) | <0.001 |
| Family history of early CAD, n (%) | 47 (54.65) | 26 (32.91) | 0.007 |
Abbreviations: BMI body mass index, CAD coronary artery disease, CK creatine kinase, CKMB isoform of CK, Fib fibrinogen, HbA1c glycated hemoglobin, HDL-C high-density lipoprotein cholesterol, MI myocardial infarction, NHDL-C non-HDL-C, TC total cholesterol, TG triglyceride, TNI troponin I, STEMI ST-segment elevation myocardial infarction.
Note: Data are expressed as mean ± standard deviation or medians (Q1, Q3).